AFFF Firefighting Foam Lawsuit (PFAS)
Aqueous Film Forming Foam (AFFF) contains PFAS "forever chemicals" linked to cancer in firefighters and contaminated communities.
Last updated: 2026-03-01
What Is This Lawsuit About?
The AFFF Firefighting Foam lawsuit involves claims against the manufacturers of Aqueous Film Forming Foam (AFFF), a specialized firefighting foam that has been used for decades to suppress petroleum-based fires at military bases, airports, fire training facilities, and industrial sites. The foam contains PFAS (per- and polyfluoroalkyl substances), a class of synthetic chemicals often referred to as "forever chemicals" because they do not naturally break down in the environment or the human body.
AFFF was developed in the 1960s by 3M in collaboration with the U.S. Navy and became the standard firefighting foam for combating jet fuel and petroleum fires. For decades, it was used extensively during both emergency fire response and routine training exercises at thousands of locations across the United States. Each use released PFAS compounds into the soil and groundwater, creating widespread contamination of drinking water supplies.
Thousands of firefighters, military personnel, and community members allege that they developed serious health conditions — including kidney cancer, testicular cancer, thyroid disease, and ulcerative colitis — as a result of PFAS exposure from AFFF. Plaintiffs claim that manufacturers like 3M and DuPont knew about the dangers of PFAS for decades but failed to warn users or the public.
The litigation is consolidated in MDL 2873 in the United States District Court for the District of South Carolina, before Judge Richard Gergel. The MDL includes claims from both public water systems (seeking cleanup costs) and individuals (seeking compensation for health injuries). In 2023, 3M agreed to pay $10.3 billion to settle water utility claims, and DuPont/Chemours settled for $1.185 billion. Personal injury claims for firefighters and affected community members continue to proceed through the courts.
Who Qualifies?
The AFFF lawsuit encompasses a broad range of individuals who were exposed to PFAS through firefighting foam. The two primary groups are those who directly handled and used AFFF (firefighters and military personnel) and those who were exposed indirectly through contaminated drinking water (community members living near AFFF-use sites).
To qualify, you must demonstrate both a history of PFAS exposure connected to AFFF and a diagnosis of a qualifying health condition. An experienced attorney can help you evaluate the strength of your claim based on your specific circumstances.
Do You Qualify for the AFFF Lawsuit?
You may be eligible to file an AFFF claim if the following apply to you:
- Military or civilian firefighters who regularly used AFFF during training or emergency response
- Military personnel stationed at bases where AFFF was used for fire training exercises
- Airport workers at facilities where AFFF was routinely deployed
- Residents living near military bases, airports, or fire training facilities with PFAS contamination
- Diagnosed with a qualifying health condition: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, or other PFAS-linked conditions
- Workers involved in manufacturing, transporting, or storing AFFF products
- Community members whose drinking water was contaminated by PFAS from AFFF use
How PFAS Exposure Occurs
Understanding how PFAS from AFFF reaches people is critical to establishing exposure in a legal claim. The contamination pathway typically follows a predictable pattern from foam use to human exposure:
AFFF/PFAS Exposure Pathway
Firefighters face particularly high exposure risk because they come into direct contact with AFFF during training exercises and emergency fire suppression. The foam can be absorbed through the skin, inhaled as mist or vapor, and ingested if protective equipment is not properly used. Military firefighters and those at bases with dedicated fire training areas (known as "burn pits" or fire training areas) may have had the most intense and prolonged exposure.
Community members living near military bases, airports, and fire training facilities can be exposed through contaminated drinking water. PFAS from AFFF use seeps into the ground and migrates into aquifers that supply municipal and private wells, sometimes at levels far exceeding EPA health advisories. For more on the broader scope of PFAS contamination, see the PFAS "Forever Chemicals" lawsuit page.
Health Conditions Linked to AFFF/PFAS Exposure
Scientific research has established associations between PFAS exposure and a range of serious health conditions. The following are the primary conditions that form the basis for AFFF personal injury claims:
PFAS-Related Health Conditions
The conditions with the strongest evidentiary support in the AFFF litigation are kidney cancer, testicular cancer, thyroid disease (including thyroid cancer), and ulcerative colitis. These conditions formed the basis for the C8 Science Panel findings (a panel established as part of the 2005 DuPont settlement with affected West Virginia and Ohio communities) and have been supported by subsequent independent research.
Think You May Qualify?
Get a free, no-obligation case review from an experienced attorney. You pay nothing unless you win.
Lawsuit Timeline
The AFFF litigation has evolved from early environmental contamination concerns to one of the largest mass tort actions in the federal court system. The timeline below traces the key milestones in this litigation:
Lawsuit Timeline
AFFF Developed
Aqueous Film Forming Foam (AFFF) is developed by 3M in partnership with the U.S. Navy to fight petroleum-based fires. It contains PFAS compounds that create a thin film to smother flames.
Widespread Military Adoption
The U.S. military mandates the use of AFFF at all bases, airfields, and naval vessels. Civilian airports and fire departments also adopt AFFF for combating fuel fires.
3M Phases Out PFOS
3M voluntarily phases out production of PFOS (perfluorooctane sulfonate), one of the key PFAS chemicals in AFFF, after internal studies reveal environmental persistence and health concerns.
EPA Issues Health Advisory
The EPA issues a lifetime health advisory of 70 parts per trillion for PFOA and PFOS in drinking water, bringing national attention to PFAS contamination near military bases and airports.
MDL 2873 Created
The Judicial Panel on Multidistrict Litigation consolidates AFFF lawsuits into MDL 2873 in the District of South Carolina, assigned to Judge Richard Gergel.
3M Settles for $10.3B
3M agrees to pay $10.3 billion over 13 years to settle claims from public water systems across the United States contaminated by PFAS from AFFF and other sources.
DuPont/Chemours Settle
DuPont, Chemours, and Corteva agree to pay $1.185 billion to settle PFAS water contamination claims from public water utilities.
Personal Injury Claims Proceed
While water utility claims have seen major settlements, personal injury claims from firefighters and community members continue through the MDL. Bellwether trials for personal injury cases are being scheduled.
Settlement Amounts & Verdicts
The AFFF litigation has already produced two landmark settlements for public water system claims:
$10.3 Billion
3M Settlement (2023)
To be paid over 13 years to public water systems contaminated by PFAS. Covers testing, treatment, and remediation costs.
$1.185 Billion
DuPont/Chemours Settlement (2023)
DuPont, Chemours, and Corteva collectively agreed to settle water utility PFAS claims.
Important distinction: The above settlements are for public water system claims (municipalities suing for water treatment and cleanup costs), not for individual personal injury claims. Personal injury claims from firefighters and community members with health conditions are a separate track within MDL 2873 and are still proceeding through litigation.
Individual personal injury settlement amounts have not yet been established through bellwether trials, but they are expected to vary significantly based on the type and severity of the health condition, the duration and intensity of PFAS exposure, and the strength of causation evidence. For context on how mass tort settlement amounts are typically determined, see our detailed guide.
Estimated Settlement Ranges
These ranges are estimates based on publicly available settlement data and comparable cases. Individual results vary significantly.
How to File an AFFF Claim
If you are a firefighter, military veteran, or community member who has been diagnosed with a health condition linked to PFAS exposure from AFFF, the following steps outline the process for pursuing a legal claim. For a broader overview of how this type of litigation works, see our guide on how mass tort lawsuits work.
How the Process Works
Identify Your AFFF Exposure
Determine how you were exposed to AFFF: as a firefighter using the foam, as military personnel at a base where AFFF was used, or as a resident near a contaminated facility.
Document Your Health Condition
Gather medical records showing a diagnosis of a PFAS-linked condition such as kidney cancer, testicular cancer, thyroid disease, or ulcerative colitis.
Consult a Qualified Attorney
Contact an experienced AFFF/PFAS attorney for a free case evaluation. These cases are complex and require knowledge of both environmental and product liability law.
File Your Lawsuit
Your attorney will file your case, which will likely be consolidated into MDL 2873 in the District of South Carolina for pretrial proceedings.
Discovery & Evidence Gathering
Your legal team will gather evidence including your exposure history, medical records, employment records, and expert testimony connecting PFAS exposure to your condition.
Settlement Negotiations or Trial
As bellwether trials establish precedent and settlement values, your case may be resolved through a negotiated settlement or proceed to trial.
Named Defendants
The AFFF litigation targets the companies that manufactured, marketed, and sold AFFF products containing PFAS compounds. The major defendants include:
- • 3M Company — Developed the original AFFF formulation and was the primary manufacturer of PFOS-based AFFF for decades. Agreed to $10.3 billion water utility settlement in 2023. Internal documents revealed that 3M knew about the persistence and bioaccumulation of PFAS as early as the 1970s.
- • DuPont / Chemours / Corteva — DuPont manufactured PFOA (C8), a PFAS compound used in products including AFFF. Chemours (spun off from DuPont in 2015) and Corteva Agriscience are also defendants. Collectively settled water utility claims for $1.185 billion.
- • Tyco Fire Products / Johnson Controls — Major manufacturer and distributor of AFFF firefighting foam products used by fire departments and military installations nationwide.
- • Kidde-Fenwal (Carrier Global) — Manufactured AFFF products sold to military and civilian fire departments.
- • National Foam / Angus Fire — Manufacturers of AFFF firefighting foam concentrates used in both military and commercial firefighting applications.
Scientific & Medical Evidence
The scientific foundation for the AFFF lawsuit draws from decades of research on PFAS health effects, including both independent academic studies and findings from corporate and government investigations:
C8 Science Panel (2005-2012)
Established as part of a settlement between DuPont and communities in West Virginia and Ohio, this independent panel of epidemiologists studied 69,000+ people exposed to PFOA through contaminated water. The panel found "probable links" between PFOA exposure and six health conditions: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, and pre-eclampsia.
National Academies of Sciences Report (2022)
A comprehensive review by the National Academies identified associations between PFAS exposure and decreased antibody response to vaccines, dyslipidemia (abnormal cholesterol), decreased infant and fetal growth, kidney cancer, and testicular cancer, among other conditions.
EPA PFAS Health Advisories
In 2022, the EPA dramatically lowered its health advisory levels for PFOA and PFOS in drinking water to near-zero levels (0.004 and 0.02 parts per trillion, respectively), reflecting the growing scientific consensus about the health dangers of even very low PFAS exposure. In 2024, the EPA established the first enforceable Maximum Contaminant Levels (MCLs) for PFAS in drinking water.
Firefighter Cancer Studies
Multiple studies have found elevated PFAS levels in the blood of firefighters compared to the general population. A 2020 study published in Environmental Health Perspectives found that firefighters had significantly elevated levels of PFOS and other PFAS, with levels correlating to years of service and frequency of AFFF use during training.
The scientific evidence connecting PFAS from AFFF to health conditions continues to grow. Related environmental contamination lawsuits, including the Camp Lejeune water contamination lawsuit, share similar themes of long-term toxic exposure and delayed corporate accountability.
Frequently Asked Questions
Frequently Asked Questions
What is AFFF and why is it dangerous?
Who qualifies for the AFFF firefighting foam lawsuit?
How much is the AFFF settlement worth?
Can volunteer firefighters file AFFF claims?
What health conditions are linked to AFFF exposure?
How is the AFFF lawsuit different from the PFAS water contamination lawsuit?
Is there a deadline to file an AFFF lawsuit?
What about military veterans who were exposed to AFFF?
Legal Disclaimer
This is for informational purposes only and does not constitute legal advice. It does not create an attorney-client relationship. The information presented may not reflect the most current legal developments. Consult a qualified attorney in your jurisdiction for advice about your specific situation.
Free Case Review — See If You Qualify
No obligation. No upfront costs. Attorneys work on contingency — you pay nothing unless you win.
Related Lawsuits
Roundup Lawsuit
Roundup herbicide containing glyphosate has been linked to non-Hodgkin lymphoma. Bayer has paid billions in settlements.
PFAS Chemicals Lawsuit
PFAS contamination of drinking water across the United States has led to billions in settlements from 3M, DuPont, and other manufacturers.
Dupixent Lawsuit
Dupixent (dupilumab) for eczema and asthma linked to cutaneous T-cell lymphoma at 30x the rate of other medications. FDA flagged the risk in March 2025.